FabRx Ltd., a pioneer in 3D printing of pharmaceuticals that is actually a spin-off from University College London (UCL), has released the first pharmaceutical 3D printer M3DIMAKER™ for the manufacture of personalised medicines. The novel system has been rigorously tested in hospitals, pharmacies and research institutes around the world.
FabRx, a leader in 3D printing of pharmaceuticals, has successfully accomplished the world’s first in-human clinical study using their proprietary Printlets™ technology. This…
